GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (LTS:0A4M) » Definitions » Additional Paid-In Capital

DexCom (LTS:0A4M) Additional Paid-In Capital : $2,051 Mil(As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is DexCom Additional Paid-In Capital?


DexCom's quarterly additional paid-in capital declined from Mar. 2024 ($2,511 Mil) to Jun. 2024 ($1,992 Mil) but then increased from Jun. 2024 ($1,992 Mil) to Sep. 2024 ($2,051 Mil).

DexCom's annual additional paid-in capital increased from Dec. 2021 ($2,109 Mil) to Dec. 2022 ($2,258 Mil) and increased from Dec. 2022 ($2,258 Mil) to Dec. 2023 ($3,515 Mil).


DexCom Additional Paid-In Capital Historical Data

The historical data trend for DexCom's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Additional Paid-In Capital Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,675.90 2,125.30 2,108.70 2,258.10 3,514.60

DexCom Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,618.00 3,514.60 2,510.60 1,992.30 2,050.50

DexCom Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

DexCom Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of DexCom's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom Headlines

No Headlines